News
Australia medical regulator approves AstraZeneca name change
Australia’s regulatory authority has approved a name change for the COVID-19 vaccine AstraZeneca, which will now be known as Vaxzevria.
The Therapeutic Goods Administration known in short as the TGA officially approved the name change in an effort to bring the naming conventions of the vaccine in line with the European Union and Canada.
A change of name is the only change made to the vaccine
All other aspects – including ingredients, dosage, quality control and application – remain unchanged.
The Department of Health stated that the new name change is expected to “alleviate confusion” and to clarify that the vaccine produced by CSL and Seqirus in Melbourne is the same one that is produced internationally, such as in Belgium.
The name change will help facilitate international recognition for Australians who received the AstraZeneca vaccine.